Deutsche Bank AG / Key word(s): Final Results/Quarter Results 19.01.2014 21:36 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Deutsche Bank (XETRA: DBKGn.DE / NYSE: DB) today reported preliminary results. Full year 2013 results - Group income before income taxes (IBIT) of EUR 2.1 billion, up 154% from 2012 - IBIT for Core Bank, which excludes the Non-Core Operations Unit, of EUR 5.3 billion, up 41% - Group net revenues of EUR 31.9 billion fell 5% and Core Bank net revenues of EUR 31.0 billion were 5% lower, both largely reflecting revenue declines in CB&S - Group noninterest expenses of EUR 27.8 billion - Adjusted cost base of EUR 23.2 billion for Group, and EUR 21.3 billion for Core Bank were down 6% and 7% respectively - Operational Excellence program achieved cumulative savings of EUR 2.1 billion, cost-to-achieve (CtA) was EUR 1.3 billion in the year - Litigation expenses of EUR 2.5 billion in 2013 as the bank put many major legacy issues behind it. Litigation reserves were EUR 2.3 billion at year end - Total assets (adjusted) at year end fell 11% to EUR 1.1 trillion for Group, and Core Bank adjusted assets fell 8% to EUR 1.0 trillion - CRD 4 leverage exposure of EUR 1.5 trillion was 14% lower and risk-weighted assets of EUR 355 billion were 11% lower than at end 2012 - CRD 4 Common Equity Tier 1 capital ratio was 9.7% (fully loaded) - CRD 4 leverage ratio was 3.1% (adjusted fully-loaded) - Post-tax return on average active equity in 2013 was 2% for the Group and 7% for the Core Bank Fourth quarter 2013 results - Group revenues were EUR 6.6 billion, down 16% from the prior year, largely reflecting CB&S results - Group loss before income taxes of EUR 1.2 billion - Group IBIT included material charges of EUR 623 million for Credit Valuation Adjustment (CVA), Debt Valuation Adjustment (DVA) and Funding Valuation Adjustment (FVA), EUR 509 million of CtA, and EUR 528 million for litigation Core Bank loss before income taxes was EUR 26 million - Core Bank IBIT adjusted for CVA/DVA/FVA, CtA, litigation and Other items in the quarter was EUR 1.3 billion All figures reported are preliminary and unaudited. The Annual Report 2013 and Form 20-F, including the audited financial statements, are scheduled to be filed and published on 20 March 2014. Jürgen Fitschen and Anshu Jain, Co-Chief Executive Officers, said: '2013 was the second successive year in which we have invested in the bank's future growth and in further strengthening our controls while addressing legacy issues. These factors impacted our financial results. Nonetheless, underlying core business profitability was amongst the highest of the past decade, and we have made Deutsche Bank fitter, safer and better balanced. We expect 2014 to be a year of further challenges and disciplined implementation; however, we are confident of reaching our 2015 targets and delivering on our strategic vision for Deutsche Bank.' 19.01.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Deutsche Bank AG Taunusanlage 12 60325 Frankfurt a. M. Germany Phone: +49 (0)69 910-00 Fax: +49 (0)69 910-38966 E-mail: Deutsche.Bank@db.com Internet: www.deutsche-bank.de ISIN: DE0005140008 WKN: 514000 Indices: DAX, EURO STOXX 50 Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime Standard), Hamburg, Hannover, München, Stuttgart; Terminbörse EUREX; NYSE End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Deutsche Bank AG reports preliminary full year
Top 10 Most Recent News Articles
Humberto Quintanar Strengthens McKinley Irvin's Seattle Team
Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...
Continue Reading
Approved Oil Secures Long-Term NYC Fuel Terminal Deal
Approved Oil Locks in Future with Sunoco Deal Amidst the contraction of New York City's fuel terminal landscape, securing a consistent lifeline to crucial infrastructure feels like striking gold. Approved Oil just locked down an agreement with Sunoco for a new terminal location that'll last deep into the 2040s, and it's about more than just securing a spot on the...
Continue Reading
Columbia Distributing Expands to Alaska: A Growth Move
Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...
Continue Reading
Gildan's Troubling Legal Struggles: Investor Action Alert
Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...
Continue Reading
DropGenie Nets $5M to Boost Functional Biology Reach
DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...
Continue Reading
Skechers Facing Class Action: Investors Urged to Act
Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...
Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD
Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...
Continue Reading
Ernesta Expands Southeast Reach with Atlanta Showroom
Ernesta's Southeast Play: The Atlanta Showroom Here's something to turn heads in the world of custom home design—Ernesta has just set up shop in Atlanta, a move that speaks volumes about their ambitions in the Southeast market. This isn't just about selling a few more rugs; it's a calculated step into a region ripe with design potential and a hunger for bespoke home...
Continue Reading
Gildan Activewear Faces Major Class Action Lawsuit
Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...
Continue Reading
Bertram Capital Backs MCE's Expansive Growth Vision
A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...
Continue ReadingTop 5 Most Recently Viewed Articles
Discover Opportunities at the 2026 China Clean Expo
Welcome to the China Clean Expo 2026 The 27th China Clean Expo (CCE) is set to take place from March 31 to April 3, 2026, at the Shanghai New International Expo Center. This event, organized by IM Sinoexpo with support from notable associations, including ISSA, promises to be a hub for industry leaders, innovators, and solution providers in the cleaning sector. The...
Continue Reading
Magellan Health and Calm Health Collaboration Enhances Support
Magellan Health Partners with Calm Health Magellan Health, Inc. is excited to announce a new partnership with Calm Health, aimed at providing improved mental health support for its members. This collaboration is designed to streamline the process for individuals seeking help, ensuring they receive the necessary resources in a timely manner. Understanding the Importance of...
Continue Reading
Celebrating the Visionaries: 2025 Franklin Institute Laureates
Honoring Global Innovators Across Science and Business The Franklin Institute is set to celebrate the exceptional contributions of its 2025 Franklin Institute Laureates. This illustrious occasion recognizes pioneers who have made significant advancements in science, technology, and business leadership. Among the nine distinguished honorees are trailblazers like Muyinatu...
Continue Reading
Origin Investments Launches Innovative 1031 Exchange Program
Origin Investments Enters the 1031 Exchange Market Origin Investments has marked a significant milestone by completing its first acquisition under the newly established Origin Exchange program, which focuses on Delaware Statutory Trust (DST) investments. The company has acquired The Starling, a modern multifamily community featuring 300 recently developed units,...
Continue Reading
Tenaris Sees Growth Amid Challenges in Q2 2025 Financials
Tenaris Reports Second Quarter Financial Results for 2025 Tenaris S.A. (NYSE: TS, BMV: TS.MX, Milan: TEN) has released its financial results for the second quarter of 2025, demonstrating resilience in a fluctuating market. Compared to the same period last year, there have been notable changes in performance metrics, illustrating both growth opportunities and challenges...
Continue Reading